The number of men being screened, diagnosed, and treated for prostate cancer has declined in recent years, suggests a new study.

Researchers from the University of Washington in Seattle were interested in analyzing how the 2012 U.S. Preventive Services Task Force (USPSTF) recommendation, which advised against using the prostate-specific-antigen (PSA) test for all men, has impacted prostate cancer care around the country. According to the Centers for Disease Control and Prevention (CDC), prostate cancer is the most common non-skin cancer among men in the United States.

Read the full story here